Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

E. Kimberly Vanover


  • Svp, Early Stage Clinical Dev. at Intra-Cellular Therapies Inc. (ITCI), 2019-01-09
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ITCI $12.29 592 Officer 27,068 2019-01-07 Filing
ITCI $11.81 2,184 Officer 27,660 2019-01-04 Filing
ITCI $11.37 7,380 Officer 29,844 2019-01-04 Filing
ITCI $11.10 4,834 Officer 16,861 2019-01-02 Filing
ITCI $17.46 772 Officer 12,373 2018-01-08 Filing